SCHEMBL28611580

SCHEMBL28611580

COc1ccc(COc2cc(Br)c(OC)c(C=O)c2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TUBB1 Q9H4B7 2/20 0.54
▸ NPC1 O15118 4/20 0.53
▸ RAB9A P51151 4/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ LMNA P02545 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ HPGD P15428 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ APP P05067 5/20 0.45
▸ MAOB P27338 2/20 0.44
▸ POLB P06746 1/20 0.44
▸ SMPD1 P17405 1/20 0.43
▸ FFAR1 O14842 2/20 0.43
▸ PPARG P37231 1/20 0.43
▸ PPARD Q03181 1/20 0.43
▸ PPARA Q07869 1/20 0.43
▸ HDAC8 Q9BY41 1/20 0.43
▸ MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7536318 0.89 TUBB1 (0.51) TUBB1NPC1RAB9ATDP1SMN1; SMN2
SCHEMBL4706617 0.86 NPC1 (0.59) TUBB1NPC1RAB9ATDP1SMN1; SMN2
SCHEMBL31500322 0.81 MAPT (0.50) TUBB1NPC1RAB9ATDP1SMN1; SMN2
SCHEMBL3629871 0.80 NPC1 (0.59) TUBB1NPC1RAB9ATDP1SMN1; SMN2
SCHEMBL1119262 0.80 PRKDC (0.50) TUBB1TDP1ALDH1A1LMNAMAPT
SCHEMBL18397169 0.78 ALDH1A1 (0.54) TUBB1NPC1RAB9ATDP1SMN1; SMN2
SCHEMBL7147744 0.78 TUBB1 (0.66) TUBB1NPC1RAB9ATDP1SMN1; SMN2
SCHEMBL2196341 0.78 NPC1 (0.61) TUBB1NPC1RAB9ATDP1SMN1; SMN2
SCHEMBL28611584 0.78 TUBB1 (0.74) TUBB1NPC1RAB9ATDP1SMN1; SMN2
SCHEMBL13006159 0.78 NPC1 (0.53) TUBB1NPC1RAB9ATDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113301959-A Substituted chromen-4-ones for the treatment and prevention of hepatitis B virus infection 豪夫迈·罗氏有限公司 2021-08-24 — — CN disclosed
Send feedback